OR15-2 Risk Variants at the MYO10 Locus are Associated with Metabolic Traits
PCOS confers an increased risk for obesity-related comorbidities. It has been challenging to identify precise risk genes associated with the pathogenesis of PCOS. A novel variant located within MYO10 intron 2 (rs9312937) was identified in a PCOS GWAS in the genetically isolated Finnish and related E...
Published in: | Journal of the Endocrine Society |
---|---|
Main Authors: | , , , , |
Format: | Text |
Language: | English |
Published: |
Oxford University Press
2022
|
Subjects: | |
Online Access: | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625142/ https://doi.org/10.1210/jendso/bvac150.1405 |
id |
ftpubmed:oai:pubmedcentral.nih.gov:9625142 |
---|---|
record_format |
openpolar |
spelling |
ftpubmed:oai:pubmedcentral.nih.gov:9625142 2023-05-15T16:49:09+02:00 OR15-2 Risk Variants at the MYO10 Locus are Associated with Metabolic Traits Chan, Yee Ming Styrkarsdottir, Unnur Welt, Corrine Zhu, Jia Battiola, Tess 2022-11-01 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625142/ https://doi.org/10.1210/jendso/bvac150.1405 en eng Oxford University Press http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625142/ http://dx.doi.org/10.1210/jendso/bvac150.1405 © The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com CC-BY-NC-ND J Endocr Soc Reproductive Endocrinology Text 2022 ftpubmed https://doi.org/10.1210/jendso/bvac150.1405 2022-11-20T01:49:29Z PCOS confers an increased risk for obesity-related comorbidities. It has been challenging to identify precise risk genes associated with the pathogenesis of PCOS. A novel variant located within MYO10 intron 2 (rs9312937) was identified in a PCOS GWAS in the genetically isolated Finnish and related Estonian populations. We identified PCOS risk variants at the MYO10 locus in additional PCOS populations. We hypothesized that PCOS risk variants at the locus were associated with metabolic traits. Women from Iceland (n=1347) and Boston (n=591) were diagnosed with PCOS using the Rotterdam criteria and NIH criteria, respectively, with a non-overlapping replication cohort (n=586) identified using an algorithm incorporating ICD codes and natural language processing. Controls included population controls from Iceland (effective n=1200), well-phenotyped controls from Boston (n=441) and a cohort with no PCOS diagnoses or features in the electronic medical record (EMR; n=749). We performed an association study to identify variants in the MYO10 locus associated with PCOS. We also examined the association of variants in MYO10 and 15 independent phenotypic traits in women of European ethnicity from the Boston PCOS cohort. Data were log-normalized and analyzed using linear regression, then corrected for the false discovery rate using the Benjamini-Hochberg procedure. Two novel risk variants for PCOS were identified within intron 2 of MYO10, rs31506-T (p = 1.6×10-05, OR 0.83 [95% CI 0.77-0.91]) and rs253336-A (p = 2.4×10-06, 0.82 [0.75-0.89]). The rs31506 variant is in moderate linkage disequilibrium with the novel variant rs9312937 (r(2) ≥ 0.4) and rs253336 (r(2) ≥ 0.4). The variant rs31506 maps to enhancer sites in pancreas, osteoblast and fetal adrenal cells, whereas rs253336 maps to methylation sites in adipose stem cells and ovary (pubs.broadinstitute.org/mammals/haploreg). Neither variant had eQTLs, and expression was highest in lung, thyroid, neurons, breast and ovary (gtexportal.org). Among cases and controls, the variant ... Text Iceland PubMed Central (PMC) Journal of the Endocrine Society 6 Supplement_1 A680 A680 |
institution |
Open Polar |
collection |
PubMed Central (PMC) |
op_collection_id |
ftpubmed |
language |
English |
topic |
Reproductive Endocrinology |
spellingShingle |
Reproductive Endocrinology Chan, Yee Ming Styrkarsdottir, Unnur Welt, Corrine Zhu, Jia Battiola, Tess OR15-2 Risk Variants at the MYO10 Locus are Associated with Metabolic Traits |
topic_facet |
Reproductive Endocrinology |
description |
PCOS confers an increased risk for obesity-related comorbidities. It has been challenging to identify precise risk genes associated with the pathogenesis of PCOS. A novel variant located within MYO10 intron 2 (rs9312937) was identified in a PCOS GWAS in the genetically isolated Finnish and related Estonian populations. We identified PCOS risk variants at the MYO10 locus in additional PCOS populations. We hypothesized that PCOS risk variants at the locus were associated with metabolic traits. Women from Iceland (n=1347) and Boston (n=591) were diagnosed with PCOS using the Rotterdam criteria and NIH criteria, respectively, with a non-overlapping replication cohort (n=586) identified using an algorithm incorporating ICD codes and natural language processing. Controls included population controls from Iceland (effective n=1200), well-phenotyped controls from Boston (n=441) and a cohort with no PCOS diagnoses or features in the electronic medical record (EMR; n=749). We performed an association study to identify variants in the MYO10 locus associated with PCOS. We also examined the association of variants in MYO10 and 15 independent phenotypic traits in women of European ethnicity from the Boston PCOS cohort. Data were log-normalized and analyzed using linear regression, then corrected for the false discovery rate using the Benjamini-Hochberg procedure. Two novel risk variants for PCOS were identified within intron 2 of MYO10, rs31506-T (p = 1.6×10-05, OR 0.83 [95% CI 0.77-0.91]) and rs253336-A (p = 2.4×10-06, 0.82 [0.75-0.89]). The rs31506 variant is in moderate linkage disequilibrium with the novel variant rs9312937 (r(2) ≥ 0.4) and rs253336 (r(2) ≥ 0.4). The variant rs31506 maps to enhancer sites in pancreas, osteoblast and fetal adrenal cells, whereas rs253336 maps to methylation sites in adipose stem cells and ovary (pubs.broadinstitute.org/mammals/haploreg). Neither variant had eQTLs, and expression was highest in lung, thyroid, neurons, breast and ovary (gtexportal.org). Among cases and controls, the variant ... |
format |
Text |
author |
Chan, Yee Ming Styrkarsdottir, Unnur Welt, Corrine Zhu, Jia Battiola, Tess |
author_facet |
Chan, Yee Ming Styrkarsdottir, Unnur Welt, Corrine Zhu, Jia Battiola, Tess |
author_sort |
Chan, Yee Ming |
title |
OR15-2 Risk Variants at the MYO10 Locus are Associated with Metabolic Traits |
title_short |
OR15-2 Risk Variants at the MYO10 Locus are Associated with Metabolic Traits |
title_full |
OR15-2 Risk Variants at the MYO10 Locus are Associated with Metabolic Traits |
title_fullStr |
OR15-2 Risk Variants at the MYO10 Locus are Associated with Metabolic Traits |
title_full_unstemmed |
OR15-2 Risk Variants at the MYO10 Locus are Associated with Metabolic Traits |
title_sort |
or15-2 risk variants at the myo10 locus are associated with metabolic traits |
publisher |
Oxford University Press |
publishDate |
2022 |
url |
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625142/ https://doi.org/10.1210/jendso/bvac150.1405 |
genre |
Iceland |
genre_facet |
Iceland |
op_source |
J Endocr Soc |
op_relation |
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625142/ http://dx.doi.org/10.1210/jendso/bvac150.1405 |
op_rights |
© The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
op_rightsnorm |
CC-BY-NC-ND |
op_doi |
https://doi.org/10.1210/jendso/bvac150.1405 |
container_title |
Journal of the Endocrine Society |
container_volume |
6 |
container_issue |
Supplement_1 |
container_start_page |
A680 |
op_container_end_page |
A680 |
_version_ |
1766039243524669440 |